CRDL
Cardiol Therapeutics
CRDL
CRDL
41 hedge funds and large institutions have $10.8M invested in Cardiol Therapeutics in 2024 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.25% less ownership
Funds ownership: 10.07% → 7.81% (-2.3%)
8% less capital invested
Capital invested by funds: $11.7M → $10.8M (-$912K)
Holders
41
Holding in Top 10
–
Calls
$897K
Puts
$18K
Top Buyers
| 1 | +$330K | |
| 2 | +$202K | |
| 3 | +$157K | |
| 4 |
LSA
Lion Street Advisors
Austin,
Texas
|
+$121K |
| 5 |
UBS AM
Chicago,
Illinois
|
+$111K |
Top Sellers
| 1 | -$3.32M | |
| 2 | -$69.1K | |
| 3 | -$49.3K | |
| 4 |
Two Sigma Advisers
New York
|
-$29.9K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$26.6K |